Financial

Mesoblast Reports First Quarter Ended September 30, 2018 Financial Results and Operational Highlights

MELBOURNE, Australia and NEW YORK, Nov. 15, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today reported strong financial results and provided operational highlights for the first quarter ended September 30, 2018. Key financial results for the three months ended September 30, 2018 (first quarter FY2019) Significant increase in revenues to […]

From Diagnostics and Delivery to Disease Prevention; Measuring the Impact of AI in Healthcare

by Ken Dropiewski, Principal Consultant – McDermott &Bull Executive Search  Executive Summary: This white paper discussion centers on ways in which three distinct branches of healthcare are currently being impacted by the introduction or use of artificial intelligence (AI). I’ll take a look, via case studies, at various ways AI is […]

Orchestra BioMed™ Announces Completion of $41 Million Financing

NEW HOPE, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing advanced therapeutic solutions to address major unmet medical needs, today announced the successful final closing of a $41 million private equity financing, which also included the conversion of outstanding […]

ARCA biopharma Announces Third Quarter 2018 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., Nov. 14, 2018 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today reported financial results for the quarter ended September 30, 2018 and provided a corporate update. “We remain focused on advancing the […]

Neovasc Announces Third Quarter 2018 Financial Results

VANCOUVER, Nov. 14, 2018 /PRNewswire/ – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCNTSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today reported financial results for the third quarter ended September 30, 2018. “In […]

HeartFlow Receives National Reimbursement Approval in Japan

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommendation by the Central Social Insurance Medical Council (Chuikyo) to provide reimbursement for the HeartFlow FFRct Analysis. The HeartFlow Analysis has already received regulatory approval from the Japanese Pharmaceuticals and Medical […]

Ra Medical Systems Reports Third Quarter 2018 Results

CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE: RMED) (the Company), a commercial-stage medical device company leveraging its advanced, minimally-invasive excimer laser-based platform for use in the treatment of vascular and dermatological diseases, today reported its financial results for the three and nine-month period ended September 30, 2018. “The third quarter of […]

Acasti Pharma Provides Business Update for Second Quarter of Fiscal 2019

LAVAL, Québec, Nov. 14, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today provided a business update and announced […]

Catasys to Announce Third Quarter 2018 Results and Host Conference Call on November 14, 2018

LOS ANGELES–(BUSINESS WIRE)–Catasys, Inc. (NASDAQ:CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the Company will be releasing financial results for its third quarter and nine months ended September 30, 2018, after the closing of the stock market on Wednesday, November 14, 2018. The Company […]

Hancock Jaffe Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance

IRVINE, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) — Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, today announced that Chris Sarner will be joining the company as its Vice President of Regulatory Affairs and Quality Assurance. Ms. Sarner will […]